期刊文献+

TG/HDLC值与ACS患者经皮冠状动脉介入治疗术后院内主要不良心血管事件的相关性 被引量:4

The relationship between TG/HDLC ratio and in-hospital major adverse cardiac events in acute coronary syndrome after percutaneous coronary intervention
下载PDF
导出
摘要 目的研究血清TG/HDLC值与急性冠状动脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)术后院内主要不良血管事件(MACE)的相关性。方法选取2014年1月至2015年1月洛阳市中心医院接受PCI治疗的患者214例,应用多因素Logistic回归分析TG/HDLC是否可作为ACS患者发生院内主要不良血管事件的独立危险因素,根据TG/HDLC值分为高TG/HDLC值组(66例)、中TG/HDLC值组(74例)、低TG/HDLC值组(74例),对三组患者院内发生主要不良心血管事件的风险进行比较。结果多因素Logistic回归模型中,通过校正年龄、性别、吸烟史、高血压病史、糖尿病史和冠状动脉狭窄程度,Log TG/HDLC值是ACS患者院内主要不良血管事件的独立危险因素(OR=6.90,95%CI为1.90~25.06,P=0.003),高TG/HDLC值组发生不良心血管事件风险是低TG/HDLC值组的3.27倍。结论 TG/HDLC值对ACS患者PCI术后院内主要不良心血管事件的发生具有重要的预测价值。 Aim To explore the relationship between the TG/HDLC ratio and in-hospital MACE in acute coronary syndrome( ACS) after percutaneous coronary intervention( PCI). Methods A total of 214 ACS patients receiving primary PCI admitted in our hospital from January 2014 to January 2015 were enrolled in this study. Multivariate analysis was conducted to assess whether TG/HDLC ratio was the independent predictor for in-hospital MACE occurrence.And the subjects were divided into three groups according to TG/HDLC ratio. The differences OR of in-hospital MACE between low TG/HDLC ratio group( n = 66),middle TG/HDLC ratio group( n = 74) and high TG/HDLC ratio group( n =74) were compared. Results After adjusting for age,smoking,hypertension,diabetes,and severity of angiographic coronary disease by the multivariate Logistic regression model,the Log TG/HDLC ratio was the independent risk factor for in-hospital MACE( OR = 6.90,95%CI was 1.90 ~ 25.06,P = 0.003). ACS patients with the higest tertile of TG/HDLC ratio exhibited multivariable-adjusted OR of 3.27 for in-hospital MACE compared with ACS patients with the lowest quartile of TG/HDLC ratio. Conclusion The TG/HDLC ratio is a powerful independent predictor of MACE.
作者 吴鹏宇 张守彦 WU Peng-Yu;ZHANG Shou-Yan(Cardiovascular Department, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China;Cardiovascular Department, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan 471000, China)
出处 《中国动脉硬化杂志》 CAS 2018年第3期277-280,共4页 Chinese Journal of Arteriosclerosis
基金 洛阳市科技攻关计划项目(1201050A-1)
关键词 急性冠状动脉综合征 甘油三酯 高密度脂蛋白胆固醇 主要不良心血管事件 Acute coronary syndrome Triglyceride High density lipoprotein cholesterol Major adverse car-diac events
  • 相关文献

参考文献4

二级参考文献37

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2149
  • 2Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable an- gina/non - ST - elevation myocardial infarction [ J]. JACC, 2007, 50: e3-e157.
  • 3Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvasta- tin, and pravastatin across doses (STELLAR Trial) [J]. Am J Cardiol, 2003, 92: 152-160.
  • 4Desch S, Eitel I, Schmitt J, et al. Effect of coronary collaterals on microvascular obstruction as assessed by magnetic resonance imaging in patients with acute ST-- elevation myocardial infarc- tion treated by primary coronary intervention [J]. Am J Cardi- oi, 2009,104: 1204- 1209.
  • 5Rodes--Cabau J, Tardif JC, Cossette M, et al. Acute effects of statin therapy on coronary atheroselerosis following an acute coronary syndrome [J]. Am J Cardiol, 2009, 104 (6): 750- 757.
  • 6Nakamura K, Sasaki T, Cheng XW, et al. Statin prevents plaque disruption in apoE--knockout mouse model through pleio tropic effect on acute inflammation [J]. Atherosclerosis, 2009, 206 (2): 355- 361.
  • 7Chan AW, Bhatt DL, Chew DP, et al. Early and sustained survival benefit associated with statin therapy at the time of per- cutaneous coronary intervention [J]. Circulation, 2002, 105: 691-696.
  • 8Pasceri V, Patti G, Nusca A, et al. Randomized trial of atorv- astatin for reduction of myocardial damage during coronary inter- vention: results from the ARMYDA (Atorvastatin for Reduc- tion of Myocardial Damage during Angioplasty) study[J]. Cir- culation, 2004, 110: 674 -678.
  • 9Oravec S,Dostal E,Dukát A. HDL subfractions analysis:a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia[J].Neuro Endocrinol Lett,2011,(04):502-509.
  • 10Staniak HL,Salgado Filho W,Miname MH. Association be-tween postprandial triglycerides and coronary artery disease de-tected by coronary computed tomography angiography[J].Ather-osclerosis,2014,(02):381-386.

共引文献56

同被引文献63

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部